These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 12696188

  • 1. [Two cases of prostate cancer associated with acute myeloid leukemia presenting as thrombocytopenia during endocrine therapy].
    Matsuura H, Sakurai M, Arima K.
    Hinyokika Kiyo; 2003 Feb; 49(2):87-90. PubMed ID: 12696188
    [Abstract] [Full Text] [Related]

  • 2. [Study on prevention of flare-up phenomenon following initial LH-RH analogue administration: combination therapy with diethylstilbestrol].
    Takeuchi S, Yoshida K, Tosaka A, Kobayashi N, Higashi Y, Negishi T.
    Hinyokika Kiyo; 1995 Mar; 41(3):191-6. PubMed ID: 7741071
    [Abstract] [Full Text] [Related]

  • 3. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators.
    Cancer; 2006 Apr 15; 106(8):1708-14. PubMed ID: 16544313
    [Abstract] [Full Text] [Related]

  • 4. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
    Scherr DS, Pitts WR.
    J Urol; 2003 Nov 15; 170(5):1703-8. PubMed ID: 14532759
    [Abstract] [Full Text] [Related]

  • 5. Mitoxantrone-associated acute myelogenous leukemia in a patient with high-risk adenocarcinoma of the prostate: a case report and brief review.
    Bowles DW, Flaig TW.
    Cancer Invest; 2006 Nov 15; 24(5):517-20. PubMed ID: 16939961
    [Abstract] [Full Text] [Related]

  • 6. Massive pleural effusions from prostatic lymphangitic carcinomatosis: resolution with endocrine therapy.
    Heffner JE, Duffey DJ, Schwarz MI.
    Arch Intern Med; 1982 Feb 15; 142(2):375-6. PubMed ID: 7059263
    [Abstract] [Full Text] [Related]

  • 7. Anticancer effect of combination therapy of VP16 and fosfesterol in hormone-refractory prostate cancer.
    Azuma H, Sakamoto T, Kiyama S, Ubai T, Kotake Y, Inamoto T, Takahara K, Nishimura Y, Segawa N, Katsuoka Y.
    Am J Clin Oncol; 2008 Apr 15; 31(2):188-94. PubMed ID: 18391605
    [Abstract] [Full Text] [Related]

  • 8. [A case of prostate cancer treated with combined androgen-blockade].
    Kurita M, Kato Y, Tamura Y, Suzuki K, Yamanaka H.
    Gan To Kagaku Ryoho; 2000 Feb 15; 27(2):307-10. PubMed ID: 10700907
    [Abstract] [Full Text] [Related]

  • 9. Changes in chromogranin a serum levels during endocrine therapy in metastatic prostate cancer patients.
    Sasaki T, Komiya A, Suzuki H, Shimbo M, Ueda T, Akakura K, Ichikawa T.
    Eur Urol; 2005 Aug 15; 48(2):224-9; discussion 229-30. PubMed ID: 16005374
    [Abstract] [Full Text] [Related]

  • 10. Neuroendocrine differentiation of localized prostate cancer during endocrine therapy.
    Nemoto K, Tomita Y.
    Scand J Urol Nephrol; 2007 Aug 15; 41(6):558-60. PubMed ID: 17853028
    [Abstract] [Full Text] [Related]

  • 11. [Prostatic cancer with cystic formation: a case report].
    Kubo M, Taguchi K, Fujisue H, Ihara H, Ikoma F.
    Hinyokika Kiyo; 1998 Dec 15; 44(12):883-6. PubMed ID: 10028435
    [Abstract] [Full Text] [Related]

  • 12. Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111.
    Hussain M, Tangen CM, Lara PN, Vaishampayan UN, Petrylak DP, Colevas AD, Sakr WA, Crawford ED, Southwest Oncology Group.
    J Clin Oncol; 2005 Dec 01; 23(34):8724-9. PubMed ID: 16314632
    [Abstract] [Full Text] [Related]

  • 13. Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.
    Kaku H, Saika T, Tsushima T, Ebara S, Senoh T, Yamato T, Nasu Y, Kumon H.
    Prostate; 2006 Mar 01; 66(4):439-44. PubMed ID: 16329145
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of adjuvant intermittent endocrine therapy following neoadjuvant endocrine therapy and external beam radiation therapy in men with locally advanced prostate cancer.
    Yamanaka H, Ito K, Naito S, Tsukamoto T, Usami M, Fujimoto H, Matsuoka N, Fukui I, Harada M, Ohashi Y, Kotake T, Kakizoe T.
    Prostate; 2005 Apr 01; 63(1):56-64. PubMed ID: 15468166
    [Abstract] [Full Text] [Related]

  • 15. Endocrine treatment of prostate cancer.
    Tammela T.
    J Steroid Biochem Mol Biol; 2004 Nov 01; 92(4):287-95. PubMed ID: 15663992
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Absence of Bcl-2 expression favors response to the short-term administration of diethylstilbestrol diphosphate in prostate Cancer.
    Nagaoka A, Kubota Y, Kurosu S, Nakada T, Bilim V, Tomita Y, Motoyama T.
    Prostate; 2006 Dec 01; 66(16):1779-87. PubMed ID: 16998806
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS, Ayala G, Aguilar L, Mai WY, Timme TL, Vlachaki MT, Miles B, Kadmon D, Wheeler T, Caillouet J, Davis M, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Aguilar-Cordova E, Butler EB.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1520-9. PubMed ID: 15050332
    [Abstract] [Full Text] [Related]

  • 20. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
    Koutsilieris M, Mitsiades CS, Bogdanos J, Dimopoulos T, Karamanolakis D, Milathianakis C, Tsintavis A.
    Clin Cancer Res; 2004 Jul 01; 10(13):4398-405. PubMed ID: 15240528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.